{"id":"W2984884245","doi":"10.1016/j.eururo.2019.10.002","title":"Efficacy, safety, and tolerability of mirabegron in patients aged ≥65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR)","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Alberta","funders":"Pfizer Canada; Astellas Pharma Global Development; Astellas Pharma; Astellas Pharma Canada","keywords":"Medicine; Tolerability; Overactive bladder; Mirabegron; Placebo; Urology; Pillar; Double blind; Safety profile; Adverse effect; Surgery; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001880583,0.0002951535,0.001142322,0.000274966,0.00006264364,0.00001674634,0.0001507222,0.00007327188,0.0004001959],"category_scores_gemma":[0.000199007,0.0002126862,0.00009400766,0.0002399305,0.0001849413,0.0001016513,0.0001622882,0.0006154466,0.00006748015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004545716,"about_ca_system_score_gemma":0.0001065531,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005194546,"about_ca_topic_score_gemma":0.00003278795,"domain_scores_codex":[0.9958778,0.001907333,0.0007103947,0.0006412979,0.0004071209,0.0004560324],"domain_scores_gemma":[0.9980388,0.0008292759,0.0002236156,0.0005499073,0.0001715265,0.0001868629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7783766,0.005430966,0.211214,0.0000462165,0.0004478503,0.0001935782,0.00255425,0.00003950292,0.0003593423,0.000003136405,0.00002869002,0.001305874],"study_design_scores_gemma":[0.6352484,0.0175437,0.3462695,0.0000148192,0.0001647128,0.00001766676,0.000189664,0.00008218206,0.00004652849,0.000002355314,0.0002827917,0.0001376742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9766693,0.0001319728,0.00001072592,0.000244021,0.00006872814,0.009039233,0.00001468189,0.00002740598,0.01379395],"genre_scores_gemma":[0.9991518,0.00004062702,0.00001967847,0.0001295689,0.0000443838,0.00004582271,0.00004991153,0.00005389751,0.0004643085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1431282,"threshold_uncertainty_score":0.8673093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02021618769318475,"score_gpt":0.3040407910611911,"score_spread":0.2838246033680064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}